Expanding Saga of the Renin-Angiotensin System The Angiotensin II Counter-Regulatory AT2 Receptor Pathway

[1] History about the discovery of the renin-angiotensin system [J]. HYPERTENSION, 2001, 38 (06) : 1246 - 1249

[2] Losartan increases bradykinin levels in hypertensive humans [J]. CIRCULATION, 2005, 111 (03) : 315 - 320

[3] de Gasparo M, 2000, PHARMACOL REV, V52, P415

[4] ACE2: more of Ang-(1-7) or less Ang II? [J]. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2011, 20 (01) : 1 - 6

[5] An Effective Approach to High Blood Pressure Control A Science Advisory From the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention [J]. HYPERTENSION, 2014, 63 (04) : 878 - 885

[6] Goldblatt H, 1934, J EXP MED, V59, P347, DOI 10.1084/jem.59.3.347

[7] Angioprotectin: an angiotensin II-like peptide causing vasodilatory effects [J]. FASEB JOURNAL, 2011, 25 (09) : 2987 - 2995

[8] Jugdutt B.I., 2014, Aging and Heart Failure: Mechanisms and Management, P259

[9] Clinical effectiveness of telmisartan alone or in combination therapy for controlling blood pressure and vascular risk in the elderly [J]. CLINICAL INTERVENTIONS IN AGING, 2010, 5 : 403 - 416

[10] Valsartan in the treatment of heart attack survivors [J]. VASCULAR HEALTH AND RISK MANAGEMENT, 2006, 2 (02) : 125 - 138

[1] History about the discovery of the renin-angiotensin system [J]. HYPERTENSION, 2001, 38 (06) : 1246 - 1249

[2] Losartan increases bradykinin levels in hypertensive humans [J]. CIRCULATION, 2005, 111 (03) : 315 - 320

[3] de Gasparo M, 2000, PHARMACOL REV, V52, P415

[4] ACE2: more of Ang-(1-7) or less Ang II? [J]. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2011, 20 (01) : 1 - 6

[5] An Effective Approach to High Blood Pressure Control A Science Advisory From the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention [J]. HYPERTENSION, 2014, 63 (04) : 878 - 885

[6] Goldblatt H, 1934, J EXP MED, V59, P347, DOI 10.1084/jem.59.3.347

[7] Angioprotectin: an angiotensin II-like peptide causing vasodilatory effects [J]. FASEB JOURNAL, 2011, 25 (09) : 2987 - 2995

[8] Jugdutt B.I., 2014, Aging and Heart Failure: Mechanisms and Management, P259

[9] Clinical effectiveness of telmisartan alone or in combination therapy for controlling blood pressure and vascular risk in the elderly [J]. CLINICAL INTERVENTIONS IN AGING, 2010, 5 : 403 - 416

[10] Valsartan in the treatment of heart attack survivors [J]. VASCULAR HEALTH AND RISK MANAGEMENT, 2006, 2 (02) : 125 - 138